Please see below all current gastrointestinal cancer clinical trials of the Central Coast Cancer Centre.
Medical Oncology clinical trials
Name: OXTOX
Can oxaliplatin neurotoxicity be reduced with ibudilast in people with metastatic colorectal cancer – a phase II randomised study
Principal Investigator: Dr Matthew Wong
Study Coordinator: Bronwyn Raymond
Status: Recruiting
Condition: Colorectal Cancer
More information about OXTOX
Name: INTEGRATE II
A Randomised Phase III Double-Blind Placebo-Controlled Study of regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)
Principal Investigator: Dr Matthew Wong
Study Coordinator: Bronwyn Raymond
Status: Recruiting
Condition: Gastrointestinal Cancer
More information about INTEGRATE II
Name: Protocol 8951-CL-5201
A phase 2, open-label, randomized study to assess the antitumor activity and safety of Zolbetuximab (IMAB362) in combination with Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as first line treatment in subjects with Claudin 18.2 (CLDN 18.2) positive, metastatic pancreatic adenocarcinoma.
Principal Investigator: Dr Matthew Wong
Study Coordinator: Michelle Dixon
Status: Recruiting
Condition: Pancreatic Cancer
More information about Protocol 8951-CL-5201
Name: MK 6482
An Open-label, multicentre, phase II study to evaluate the efficacy and safety of pembrolizumab plus lenvatinib in combination with belzutifan in multiple solid tumours.
Principal Investigator: Dr Matthew Wong
Study Coordinator: Cassandra Rubio
Status: Recruiting
Condition: Hepatocellular, Endometrial, Oesophageal Cancer
More information about MK 6482
Name: STAR-221
A Randomised, open-label, Multicentre Phase 3 Trial of Domvanalimab, Zimberelimab, and Chemotherapy in Participants with Previously Untreated Locally Advanced Unresectable or Metastatic gastric Gastroesophageal Junction, and Esophageal Adenocarcinoma
Principal Investigator: Dr Craig Kukard
Study Coordinator: Abraham Mathews
Status: Recruiting
Condition: Gastro-Oesophageal Cancer
More information about STAR-221
Radiation Oncology clinical trials
Name: LARK
The LARK Clinical Trial Liver Ablative Radiotherapy utilising Kilovoltage Intrafraction Monitoring (KIM).
Principal Investigator: Dr Simon Tang
Study Coordinator: Richard Clayton
Status: Recruiting
Condition: Liver Cancer
More information about LARK
More information
For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:
Research and Clinical Trials